Edition:
India

Vaxart Inc (VXRT.OQ)

VXRT.OQ on NASDAQ Stock Exchange Capital Market

3.17USD
20 Jun 2018
Change (% chg)

$0.04 (+1.28%)
Prev Close
$3.13
Open
$3.14
Day's High
$3.17
Day's Low
$3.14
Volume
204
Avg. Vol
15,017
52-wk High
$11.88
52-wk Low
$2.77

Chart for

About

Vaxart, Inc., formerly Aviragen Therapeutics, Inc., is focused on the discovery and development of direct-acting antivirals to treat infections that affect patients globally. The Company has three product candidates in clinical development that address viral infections that have limited therapeutic options. Its products include... (more)
No analyst recommendations are available for .

Overall

Beta: 0.02
Market Cap(Mil.): $27.05
Shares Outstanding(Mil.): 38.65
Dividend: --
Yield (%): --

Financials

BRIEF-Vaxart Appoints Dr. David Taylor As Chief Medical Officer

* VAXART APPOINTS DR. DAVID TAYLOR AS CHIEF MEDICAL OFFICER Source text for Eikon: Further company coverage:

01 May 2018

BRIEF-Vaxart Announces $5 Mln Inavir Revenue Milestone

* VAXART - NOTIFIED BY DAIICHI SANKYO CO THAT SALES OF INAVIR EXCEEDED ¥20 BILLION IN FISCAL YEAR 2017, TRIGGERING A $5 MILLION MILESTONE PAYMENT TO CO

20 Apr 2018

Earnings vs. Estimates